PATENT CLAIM ANALYSIS

Application Number: 15753525
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to a tablet comprising Afatinib or a pharmaceutically acceptable salt thereof, wherein the tablet is obtained by direct compression. The present invention further relates to a process for manufacturing a tablet of the invention as well as the use of the tablet of the invention.

Claim (Index 28):
A tablet comprising Afatinib dimaleate form L and lactose, wherein the tablet is obtained by direct compression.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 88.0
- Lexical Diversity: 1.67742
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15565996', '15575778', '15516382', '14995605', '13989603']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7223256908566804
- 35 USC 102 Novelty (BERT): 0.5075535593219649
- Combined Prediction Score: 0.7008484777032089
- Mean Citation Score: 204.73851
- Max Citation Score: 236.38866
- Similarity Product: 143.3316021117067

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test